Eleonora Cremonini Selected Research

cyanidin

1/2022	Supplementation with cyanidin and delphinidin mitigates high fat diet-induced endotoxemia and associated liver inflammation in mice.
1/2022	A randomized placebo-controlled cross-over study on the effects of anthocyanins on inflammatory and metabolic responses to a high-fat meal in healthy subjects.
1/2019	Anthocyanins protect the gastrointestinal tract from high fat diet-induced alterations in redox signaling, barrier integrity and dysbiosis.
1/2018	Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleonora Cremonini Research Topics

Disease

9	Insulin Resistance 01/2022 - 01/2016
8	Inflammation (Inflammations) 11/2022 - 12/2016
5	Obesity 01/2020 - 01/2016
4	Necrosis 11/2022 - 05/2015
4	Neoplasms (Cancer) 11/2022 - 05/2015
4	Endotoxemia 01/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
2	Dysbiosis 01/2020 - 01/2019
2	Overweight 01/2019 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2018
2	Cognitive Dysfunction 02/2014 - 05/2013
1	Fatty Liver 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Viral Pneumonia 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Coronavirus Infections 03/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Communicable Diseases (Infectious Diseases) 11/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Metabolic Bone Diseases (Osteopenia) 01/2016
1	Osteoporosis 01/2016
1	Hot Flashes 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 02/2014
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2014
1	Disease Progression 01/2014
1	Bone Resorption 01/2014
1	Dementia (Dementias) 05/2013

Drug/Important Bio-Agent (IBA)

7	Catechin (Z 7300)IBA 01/2020 - 05/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
4	LipidsIBA 01/2022 - 01/2018
4	delphinidinIBA 01/2022 - 01/2018
4	cyanidinIBA 01/2022 - 01/2018
4	Insulin (Novolin)FDA Link 01/2022 - 01/2016
4	flavan-3-olIBA 01/2020 - 01/2016
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 01/2018
3	Anthocyanins (Anthocyanin)IBA 01/2022 - 08/2017
3	AntioxidantsIBA 02/2014 - 05/2013
2	Oxidants (Oxidizing Agents)IBA 11/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2016
2	EndotoxinsIBA 01/2020 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	Sulfhydryl Compounds (Thiols)IBA 02/2014 - 05/2013
2	Uric Acid (Urate)IBA 02/2014 - 05/2013
2	Advanced Oxidation Protein Products (AOPP)IBA 02/2014 - 05/2013
1	CurcuminIBA 11/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022
1	lardIBA 01/2022
1	MitogensIBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	AntigensIBA 01/2022
1	Nucleic AcidsIBA 03/2021
1	Ellagic AcidIBA 01/2020
1	GlycosidesIBA 01/2019
1	MucinsIBA 01/2019
1	Claudin-1IBA 01/2019
1	OccludinIBA 01/2019
1	Pharmaceutical PreparationsIBA 11/2018
1	PalmitatesIBA 01/2018
1	CarbohydratesIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2018
1	ilomastatIBA 01/2018
1	marimastatIBA 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	FlavonoidsIBA 01/2018
1	acetovanillone (apocynin)IBA 01/2018
1	FructoseIBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	ChemokinesIBA 12/2016
1	procyanidinIBA 12/2016
1	LigandsIBA 01/2016
1	OsteoprotegerinIBA 01/2016
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2016
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2016
1	HomocysteineIBA 02/2014
1	collagen type I trimeric cross-linked peptideIBA 01/2014

Therapy/Procedure

1	Long-Term Care 01/2022
1	Therapeutics 01/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2015